| |
Company
Roster
|
|
Total
Insiders : |
21 |
|
|
|
Total
Direct Shares :
|
21,294,004 |
|
|
Total
Indirect Shares :
|
19,356,225 |
| |
%
Held by Insiders:
|
47.39% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Van Den Boom Esther |
|
|
0 |
|
0 |
| 3d Opportunity Master Fund |
10% Owner |
|
0 |
2021-01-11 |
5,502,047 |
| Essex Woodlands Health Ventures Fund Vi L P |
10% Owner |
2005-01-28 |
11,703,704 |
|
0 |
| Kissei Pharmaceutical Co., Ltd. |
10% Owner |
2011-10-13 |
800,000 |
|
0 |
| Satomi Hajime |
10% Owner |
2013-05-13 |
467,000 |
2013-05-13 |
1,000,000 |
| Tanabe Holding America Inc. |
9.9% owner |
2006-10-13 |
5,000,000 |
|
0 |
| Coffee Michael Denis |
CBO & Interim CFO |
2011-03-29 |
4,000 |
2011-03-29 |
0 |
| Kalafer Michael E |
Chief Medical Officer |
2008-06-19 |
2,023 |
2009-07-28 |
31,744 |
| Matsuda Kazuko |
Chief Medical Officer, Director |
2021-08-23 |
322,996 |
|
0 |
| Johnson Kirk William |
Chief Scientific Officer |
2011-03-29 |
1,700 |
2011-03-29 |
0 |
| Himawan Jeff |
Director |
|
0 |
2006-01-09 |
11,703,704 |
| Nakata Kousuke |
Director |
|
0 |
2011-11-29 |
800,000 |
| Morris Arlene |
Director |
2013-05-21 |
0 |
2013-05-21 |
0 |
| Izumi Tatsuo |
Director |
2013-12-12 |
600,000 |
2013-12-12 |
158,730 |
| Kobayashi Yutaka |
Director |
2017-05-15 |
81,800 |
2017-05-15 |
25,000 |
| Ishizaka Yoshio |
Director |
2017-08-21 |
5,000 |
2017-08-21 |
10,000 |
| Nagao Hideki |
Director |
2022-11-28 |
0 |
|
0 |
| Kiyoizumi Takashi |
Officer, Director |
2005-01-28 |
250,000 |
|
0 |
| Iwaki Yuichi |
President and CEO, Director |
2021-07-09 |
966,933 |
2021-07-09 |
125,000 |
| Obrien Geoffrey |
Vice President |
2021-05-19 |
48,318 |
|
0 |
| Okajima Masatsune |
VP and Head of Japanese Office |
2019-02-28 |
1,040,530 |
2016-03-14 |
0 |
|
0.06 (4.03%) 
